by kidneycell | Feb 2, 2022 | Uncategorized
Mission Viejo, California, United States, Jan. 26, 2022 (GLOBE NEWSWIRE) — Leonhardt Ventures LLC, a Mission Viejo, California based company via it’s innovation and startup launch accelerator Leonhardt’s Launchpads, announced today that it has begun...
by kidneycell | Jun 23, 2020 | Uncategorized
The KidneyCell II Clinical Trial will feature non-invasive bioelectric stimulation controlled release of the Klotho protein known to be beneficial in kidney health Topline Data Expected in 4Q 2020 Irvine, CA and Porto Allegre, Brazil – February 17th, 2020...
by kidneycell | Jun 23, 2020 | Uncategorized
Latest Patent Further Strengthens Intellectual Property Portfolio Covering Novel Platform for Precisely Controlling Regenerative Protein Expressions Including Stem Cell Homing and Differentiation Control Technology Has Key Potential Applications in Regeneration of...
by kidneycell | Jun 23, 2020 | Uncategorized
Published: Mar 13, 2019 Device, programmed bioelectric signaling sequences and methods for the controlled expression of Klotho on demand Leonhardt’s Launchpads, a Los Angeles, Salt Lake City and Pittsburgh based innovation and startup accelerator focused on...
by kidneycell | Jun 22, 2020 | Uncategorized
Leonhardt’s Launchpads, a medtech and biotech innovation and startup accelerator focused on organ regeneration and recovery technologies, today announced its expansion into Pittsburgh with the formation of Leonhardt’s Launchpads Pittsburgh. The company will be located...
Recent Comments